Stay updated on Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial page.

Latest updates to the Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial page
- Check3 days agoChange DetectedA site-wide NIH notice announces the transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedThe page now displays a 403 Forbidden error, and the detailed study content and navigation previously visible on this screen appear to have been removed, leaving only the error notice.SummaryDifference18%

- Check38 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing Revision: v3.6.6 in the revision history. This indicates an updated page revision rather than a substantive change to study information.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, reflecting a small site update.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page’s revision tag was updated from v3.6.4 to v3.6.5, representing a new version of the page.SummaryDifference0.1%

Stay in the know with updates to Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab in Adjuvant Therapy for Stage 3 MSI-High Colon Cancer Clinical Trial page.